Expanding our knowledge
of cell therapy manufacturing
OUR CAPABILITIES
Reliable partner for cell & gene therapy manufacturing
As a long-term manufacturing partner, we will strategically guide our business partners through every step of the cell therapy manufacturing chain. We offer full services covering GMP production of Advanced Therapy Medicinal Products including genetically modified and viral vectors. SCTbio leverages a decade of experience
in development of autologous cell-based products, product supply for clinical trials, GMP compliance for the full lifecycle of drug development, manufacturing, quality control, QA/QP release, storage and logistics services and process development services to deliver the highest quality collaboration for your CDMO needs.
History of SCTbio
SCTbio was formed on July 1, 2021, and is a part of PPF Biotech network. The key company and personnel capabilities have been generated within SOTIO Group, during its more than 10 years of history of drug development and manufacturing. All of SOTIO’s cell and gene therapy GMP manufacturing capabilities have been outsourced to SCTbio, including our GMP manufacturing facility in Prague, Czech Republic.
12 years
in cell and gene therapy field
2.000 sqm
facility area including 420sqm of GMP clean rooms
80+
reliable team members
Our Team
Luděk Sojka
Chief Executive Officer
Pascale Charbonnel
Chief Business Officer
[email protected]
Klára Murcková
Production Manager
Daniela Rožková
Chief Technology Officer
Martin Pávek
Chief Operating Officer
Jakub Čierný
Chief Quality Compliance Officer
We attended ISCT 2024
May 29 – April 1, 2024 in Vancouver
We attended German Biotech Days
April 16 - April 17, 2024 in Berlin
We attended EMBT global conference
April 14- April 17, 2024 in Glasgow
We attended to Cell & gene on the Med
April 09 - April 11, 2024 in Roma
SCTbio Brochure
SCTbio Your Reliable Partner for Cell & Gene Therapy GMP Manufacturing
SCTbio Brochure for Analytical Services
Check-out SCTbio full range of analytical capabilities!
We attended Advanced Therapies Congress
March 19-20, 2024 in London
We attended BIO-EUROPE FALL
November 6 - November 8, 2023 in Munich Germany
We attended ESGCT 30th ANNUAL CONGRESS
October 24 - October 27, 2023 in Brussels, Belgium
SCTbio and Cyto-care Collaborate to Improve Cell Therapy Cryopreservation and Logistics Capabilities in Europe
Source: Press Release - Prague, Czech Republic and Vienna, Austria
Orgenesis Announces Collaboration Agreement with SCTbio for the Production of Lentivirus Vectors
Source: Press Release - Germantown, MD and Prague, Czech Republic
We attended ISCT
May 31- June 3, 2023 in Paris, France
We attended The American Society of Gene & Cell Therapy (ASGCT)
May 16-20iest, 2023 in Los Angeles, California, USA
We attended Cell & Gene Meeting on the Med
April 12-14th, 2023 in Barcelona, Spain
We attended 10th Gene Quantification Event
March 20-24th, 2023 in Weihenstephan, Germany
We attended Advanced Therapies Congress
March 14-15th, 2023 in London, UK
We attended the CAR-TCR Europe
February 21-23rd, 2023 in London, UK
We attended the Viral Vector Process Development Summit
January 31- February 2nd, 2023 in Boston, MA, US
We attended the Advanced Therapies Week
January 17-23rd, 2023 in Miami, Florida, US
We attended to Cell & Gene Therapy Manufacturing & Commercialization Europe 2022
December 6-8th, 2022 in Amsterdam, NL
We attended to 3rd CELL & GENE ROUNDTABLE "X-CELLERATOR"
October 20th, 2022 in Berlin, Germany
We attended to Cell & Gene on the Mesa
October 11-13th, 2022 in Carlsbad, CA
We attended to Nordic Life Sciences Days
September 28-29th, 2022 in Malmo, Sweden
We attended to 6th International Symposium on CAR T cells (CAR T Day)
September 7-9th, 2022 in Lille, France
We attended to Advanced Therapies Europe
August 31st - September 1st, 2022 in London, UK
We attended the Advanced Therapies 2022 Congress
May 24-25, 2022 in London, UK
We attended the ASGCT 25th Annual Meeting
May 16-19, 2022 in Washington, D.C.
SCTbio Video
Take a tour of our GMP manufacturing facility in Prague.
Ukázka článku - Media
Praesent nec arcu lorem. Nulla vitae malesuada nisl, nec laoreet enim. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“SCTbio already had an impressive track record of experience with autologous cell therapy manufacturing, including not just GMP manufacturing and analytical capabilities, but a sophisticated cold chain operation, scheduling and supply chain software, and extensive network of qualified leukapheresis sites.”
“Auditing SCTbio revealed to us a company in which GMP culture is deeply rooted, the quality system is well structured, and GMP readiness is not just a marketing keyword thanks to the constant effort of SCTbio’s people, their expertise, their commitment, and their attention to quality.”
